Variant report
Variant | nsv6151 |
---|---|
Chromosome Location | chr8:35513278-35525860 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570464546 | chr8:35513313-35513314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575447786 | chr8:35513424-35513425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553055241 | chr8:35513484-35513485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112995616 | chr8:35513610-35513611 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574500560 | chr8:35513644-35513645 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542056621 | chr8:35513737-35513738 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148374582 | chr8:35513746-35513747 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186379343 | chr8:35513854-35513855 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546145606 | chr8:35513855-35513856 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565119073 | chr8:35513906-35513907 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192457696 | chr8:35513961-35513962 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541134388 | chr8:35513981-35513982 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs28676752 | chr8:35513982-35513983 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs530192359 | chr8:35513987-35513988 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548830762 | chr8:35513999-35514000 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113933529 | chr8:35514001-35514002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529058283 | chr8:35514051-35514052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569944969 | chr8:35514053-35514054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74715142 | chr8:35514077-35514078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142283808 | chr8:35514104-35514105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552470438 | chr8:35514156-35514157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183413768 | chr8:35514173-35514174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547560806 | chr8:35514184-35514185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199553969 | chr8:35514185-35514186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534614454 | chr8:35514187-35514188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146295525 | chr8:35514263-35514264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139541761 | chr8:35514277-35514278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535589962 | chr8:35514308-35514309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10092757 | chr8:35514357-35514358 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs10102232 | chr8:35519401-35519402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs187694415 | chr8:35519437-35519438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201883648 | chr8:35519475-35519476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555594854 | chr8:35519484-35519485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371902383 | chr8:35519544-35519545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112458083 | chr8:35519551-35519552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558455691 | chr8:35519582-35519583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34835642 | chr8:35519583-35519584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192378327 | chr8:35519619-35519620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183938283 | chr8:35519628-35519629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144194424 | chr8:35519667-35519668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188885814 | chr8:35519673-35519674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199546633 | chr8:35519704-35519705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10692805 | chr8:35519705-35519706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs57184461 | chr8:35519722-35519723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543039881 | chr8:35519726-35519727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11992399 | chr8:35519754-35519755 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs531827844 | chr8:35519820-35519821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145478687 | chr8:35519863-35519864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575778989 | chr8:35519985-35519986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80072660 | chr8:35520070-35520071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 20459607 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Breast cancer | 21328542 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Intellectual disability | 22045946 | CNVD |
Lung cancer | 17925434 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:35512800-35513600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:35513200-35513800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr8:35513200-35513800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr8:35513400-35514000 | Enhancers | Fetal Heart | heart |
5 | chr8:35513600-35514000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:35513600-35514400 | Enhancers | Sigmoid Colon | Sigmoid Colon |
7 | chr8:35514000-35514400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr8:35519400-35520000 | Enhancers | Fetal Lung | lung |
9 | chr8:35519600-35520200 | Enhancers | Brain Germinal Matrix | brain |
10 | chr8:35520000-35524000 | Weak transcription | Fetal Lung | lung |
11 | chr8:35520200-35522800 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr8:35524000-35524600 | Enhancers | Fetal Lung | lung |